Volume 91 Issue 21 | pp. 30-31
Issue Date: May 27, 2013

Europeans Seek Competitive Advantage From Continuous Processing

The pharmaceutical patent cliff is driving firms to look more closely at improving manufacturing processes
Department: Business
Keywords: continuous processing, batch, pharmaceutical

The spate of drug patent expirations known as the patent cliff is sharpening minds. Pharmaceutical companies have been looking under every rock to save money, and one idea they have found is continuous chemical manufacturing. Momentum to develop continuous processes is especially building in Europe, where firms hope that by working together and with academia they can get a jump on the competition.

Delegates at a meeting held recently at AstraZeneca’s R&D center . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society